APO RESEARCH · REPORT
Glycated Albumin
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy.
Product & engineering
Understand the product.
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy.
Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose present in diabetes meatus results in increased glycation of all proteins, including, albumin. Measurement of the amount of the glycation reaction resulting from the combination of glucose with free amino groups in proteins present in the blood is used to monitor the level of glucose that has generally been present in body fluids over a preceding period.
Thus serum glycated albumin assay can be used to determine the current level of glycation of albumin, the most abundant plasma protein. Hence, the gycated albumin assay may be used as a marker of glycemic control in diabetes and reflects glycemic control over the precious 2 to 4 weeks.
Selected research
Industry Growth & Trends
Global Glycated Albumin Industry Growth and Trends Forecast to 2032
Market perspective
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy.
Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose present in diabetes meatus results in increased glycation of all proteins, including, albumin. Measurement of the amount of the glycation reaction resulting from the combination of glucose with free amino groups in proteins present in the blood is used to monitor the level of glucose that has generally been present in body fluids over a preceding period.
Thus serum glycated albumin assay can be used to determine the current level of glycation of albumin, the most abundant plasma protein. Hence, the gycated albumin assay may be used as a marker of glycemic control in diabetes and reflects glycemic control over the precious 2 to 4 weeks.
Read the full market overview
The major players in global Glycated Albumin market include Asahi Kasei Pharma, DIAZYME, Abnova, etc. The top 3 players occupy about 85% shares of the global market. Asia-Pacific and Europe are main markets, they occupy about 60% of the global market. Glycated Albumin (Animal) is the main type, with a share about 60%. Hospitals and Clinics is the main application, which holds a share about 50%.
Report Scope
This report provides a structured, data-driven view of the global Glycated Albumin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Glycated Albumin market size, estimates, and forecasts are presented in terms of sales volume (Kits) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glycated Albumin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glycated Albumin.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Glycated Albumin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Glycated Albumin Market by Company
Asahi Kasei Pharma
DIAZYME
Abnova
LifeSpan
Exocell
BSBE
Medicalsystem
Maccura
Leadman
Simes Sikma
NINGBO PUREBIO
Glycated Albumin Segment by Type
Glycated Albumin (Human)
Glycated Albumin (Animal)
Glycated Albumin Segment by Application
Hospitals and Clinics
Laboratories
Glycated Albumin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycated Albumin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glycated Albumin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycated Albumin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glycated Albumin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Glycated Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Glycated Albumin (Human)
- Glycated Albumin (Animal)
Applications
- Hospitals and Clinics
- Laboratories
Companies covered
- Asahi Kasei Pharma
- DIAZYME
- Abnova
- LifeSpan
- Exocell
- BSBE
- Medicalsystem
- Maccura
- Leadman
- Simes Sikma
- NINGBO PUREBIO
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Glycated Albumin Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Glycated Albumin Sales Estimates and Forecasts (2021-2032)
- 1.3 Glycated Albumin Market by Type
- 1.3.1 Glycated Albumin (Human)
- 1.3.2 Glycated Albumin (Animal)
- 1.4 Global Glycated Albumin Market Size by Type
- 1.4.1 Global Glycated Albumin Market Size Overview by Type (2021-2032)
- 1.4.2 Global Glycated Albumin Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Glycated Albumin Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Glycated Albumin Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Glycated Albumin Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Glycated Albumin Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Glycated Albumin Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Glycated Albumin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Glycated Albumin Industry Trends
- 2.2 Glycated Albumin Industry Drivers
- 2.3 Glycated Albumin Industry Opportunities and Challenges
- 2.4 Glycated Albumin Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Glycated Albumin Revenue (2021-2026)
- 3.2 Global Top Players by Glycated Albumin Sales (2021-2026)
- 3.3 Global Top Players by Glycated Albumin Price (2021-2026)
- 3.4 Global Glycated Albumin Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Glycated Albumin Major Company Production Sites & Headquarters
- 3.6 Global Glycated Albumin Company, Product Type & Application
- 3.7 Global Glycated Albumin Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Glycated Albumin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Glycated Albumin Players Market Share by Revenue in 2025
- 3.8.3 2025 Glycated Albumin Tier 1, Tier 2, and Tier 3
4 Glycated Albumin Regional Status and Outlook
- 4.1 Global Glycated Albumin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Glycated Albumin Historic Market Size by Region
- 4.2.1 Global Glycated Albumin Sales in Volume by Region (2021-2026)
- 4.2.2 Global Glycated Albumin Sales in Value by Region (2021-2026)
- 4.2.3 Global Glycated Albumin Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Glycated Albumin Forecasted Market Size by Region
- 4.3.1 Global Glycated Albumin Sales in Volume by Region (2027-2032)
- 4.3.2 Global Glycated Albumin Sales in Value by Region (2027-2032)
- 4.3.3 Global Glycated Albumin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Glycated Albumin by Application
- 5.1 Glycated Albumin Market by Application
- 5.1.1 Hospitals and Clinics
- 5.1.2 Laboratories
- 5.2 Global Glycated Albumin Market Size by Application
- 5.2.1 Global Glycated Albumin Market Size Overview by Application (2021-2032)
- 5.2.2 Global Glycated Albumin Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Glycated Albumin Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Glycated Albumin Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Glycated Albumin Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Glycated Albumin Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Glycated Albumin Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Glycated Albumin Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Asahi Kasei Pharma
- 6.1.1 Asahi Kasei Pharma Company Information
- 6.1.2 Asahi Kasei Pharma Business Overview
- 6.1.3 Asahi Kasei Pharma Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Asahi Kasei Pharma Glycated Albumin Product Portfolio
- 6.1.5 Asahi Kasei Pharma Recent Developments
- 6.2 DIAZYME
- 6.2.1 DIAZYME Company Information
- 6.2.2 DIAZYME Business Overview
- 6.2.3 DIAZYME Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 DIAZYME Glycated Albumin Product Portfolio
- 6.2.5 DIAZYME Recent Developments
- 6.3 Abnova
- 6.3.1 Abnova Company Information
- 6.3.2 Abnova Business Overview
- 6.3.3 Abnova Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Abnova Glycated Albumin Product Portfolio
- 6.3.5 Abnova Recent Developments
- 6.4 LifeSpan
- 6.4.1 LifeSpan Company Information
- 6.4.2 LifeSpan Business Overview
- 6.4.3 LifeSpan Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 LifeSpan Glycated Albumin Product Portfolio
- 6.4.5 LifeSpan Recent Developments
- 6.5 Exocell
- 6.5.1 Exocell Company Information
- 6.5.2 Exocell Business Overview
- 6.5.3 Exocell Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Exocell Glycated Albumin Product Portfolio
- 6.5.5 Exocell Recent Developments
- 6.6 BSBE
- 6.6.1 BSBE Company Information
- 6.6.2 BSBE Business Overview
- 6.6.3 BSBE Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 BSBE Glycated Albumin Product Portfolio
- 6.6.5 BSBE Recent Developments
- 6.7 Medicalsystem
- 6.7.1 Medicalsystem Company Information
- 6.7.2 Medicalsystem Business Overview
- 6.7.3 Medicalsystem Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Medicalsystem Glycated Albumin Product Portfolio
- 6.7.5 Medicalsystem Recent Developments
- 6.8 Maccura
- 6.8.1 Maccura Company Information
- 6.8.2 Maccura Business Overview
- 6.8.3 Maccura Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Maccura Glycated Albumin Product Portfolio
- 6.8.5 Maccura Recent Developments
- 6.9 Leadman
- 6.9.1 Leadman Company Information
- 6.9.2 Leadman Business Overview
- 6.9.3 Leadman Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Leadman Glycated Albumin Product Portfolio
- 6.9.5 Leadman Recent Developments
- 6.10 Simes Sikma
- 6.10.1 Simes Sikma Company Information
- 6.10.2 Simes Sikma Business Overview
- 6.10.3 Simes Sikma Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Simes Sikma Glycated Albumin Product Portfolio
- 6.10.5 Simes Sikma Recent Developments
- 6.11 NINGBO PUREBIO
- 6.11.1 NINGBO PUREBIO Company Information
- 6.11.2 NINGBO PUREBIO Business Overview
- 6.11.3 NINGBO PUREBIO Glycated Albumin Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 NINGBO PUREBIO Glycated Albumin Product Portfolio
- 6.11.5 NINGBO PUREBIO Recent Developments
7 North America by Country
- 7.1 North America Glycated Albumin Sales by Country
- 7.1.1 North America Glycated Albumin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Glycated Albumin Sales by Country (2021-2026)
- 7.1.3 North America Glycated Albumin Sales Forecast by Country (2027-2032)
- 7.2 North America Glycated Albumin Market Size by Country
- 7.2.1 North America Glycated Albumin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Glycated Albumin Market Size by Country (2021-2026)
- 7.2.3 North America Glycated Albumin Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Glycated Albumin Sales by Country
- 8.1.1 Europe Glycated Albumin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Glycated Albumin Sales by Country (2021-2026)
- 8.1.3 Europe Glycated Albumin Sales Forecast by Country (2027-2032)
- 8.2 Europe Glycated Albumin Market Size by Country
- 8.2.1 Europe Glycated Albumin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Glycated Albumin Market Size by Country (2021-2026)
- 8.2.3 Europe Glycated Albumin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Glycated Albumin Sales by Country
- 9.1.1 Asia-Pacific Glycated Albumin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Glycated Albumin Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Glycated Albumin Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Glycated Albumin Market Size by Country
- 9.2.1 Asia-Pacific Glycated Albumin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Glycated Albumin Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Glycated Albumin Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Glycated Albumin Sales by Country
- 10.1.1 South America Glycated Albumin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Glycated Albumin Sales by Country (2021-2026)
- 10.1.3 South America Glycated Albumin Sales Forecast by Country (2027-2032)
- 10.2 South America Glycated Albumin Market Size by Country
- 10.2.1 South America Glycated Albumin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Glycated Albumin Market Size by Country (2021-2026)
- 10.2.3 South America Glycated Albumin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Glycated Albumin Sales by Country
- 11.1.1 Middle East and Africa Glycated Albumin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Glycated Albumin Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Glycated Albumin Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Glycated Albumin Market Size by Country
- 11.2.1 Middle East and Africa Glycated Albumin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Glycated Albumin Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Glycated Albumin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Glycated Albumin Value Chain Analysis
- 12.1.1 Glycated Albumin Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Glycated Albumin Production Mode & Process
- 12.2 Glycated Albumin Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Glycated Albumin Distributors
- 12.2.3 Glycated Albumin Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst